Position
Researcher – Computational Drug Design & Structural Biology Unit
Biography
Biography: Ms. Sabah Ibrahim is a dedicated and skilled biomedical researcher with strong expertise in bioinformatics, currently pursuing a Doctor of Philosophy (PhD) at Robert Gordon University, School of Pharmacy and Life Sciences, United Kingdom (2025-2029). Her doctoral research focuses on microbiology, pathogen genomics, and drug design, with a particular emphasis on the genomic analysis of multidrug-resistant pathogens and the discovery of novel therapeutic targets. She holds an M.Sc. in Biochemistry and Molecular Biology from the Graduate College, Al-Neelain University – Sudan, and a B.Sc. (Honours) in Zoology (Second Class – Upper). These academic foundations have supported her advanced development in computational biology and molecular research. With advanced proficiency in R programming, Ms. Sabah brings a comprehensive skill set in bioinformatics workflows, data analysis, genomics, and in silico drug discovery. She is actively involved in developing computational tools for pathogen characterization and antimicrobial resistance (AMR) studies. As an experienced educator and workshop facilitator, she has led numerous training sessions in bioinformatics and statistical analysis, contributing to capacity building and the advancement of genomic sciences in Sudan. Ms. Sabah is deeply committed to empowering local researchers, supporting precision medicine, and driving innovation in genomics and bioinformatics throughout Sudan and the region.
Research Interests
- Genomic characterization of multidrug-resistant bacteria
- Identification of virulence-associated proteins as drug targets
- Computer-aided drug design and virtual screening
- Development of antimicrobial agents that minimize resistance
- Precision medicine in infectious disease research
Notable Achievements
- Developing an integrated computational pipeline to identify small-molecule inhibitors against Pseudomonas aeruginosa
- Leading doctoral research focused on AMR genomics and drug target prioritization
- Contributing to novel approaches for designing resistance-resilient antimicrobial therapies
Collaborations
- PhD research collaboration with Robert Gordon University (UK)
- Involved in institutional research projects at NUBRI on antimicrobial resistance and drug discovery
- Participation in regional AMR surveillance and data integration efforts